Suzhou Kintor Pharmaceuticals

company

About

Kintor is a pharmaceutical research company.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$44M
Industries
Biopharma,Biotechnology,Health Care,Life Science,Pharmaceutical
Founded date
Jan 1, 2009
Number Of Employee
11 - 50
Operating Status
Active

Kintor founded in Suzhou in 2009, focusing on prostate cancer, breast cancer and liver cancer which account for more than 50% of the global cancer population and lack of effective treatment method. They have a product pipeline built on proprietary R&D and licensing arrangement, aiming to provide the best treatment plans for huge unmet patient needs. They focus on developing a full R&D and commercialization platform for “best-in-class” and “first-in-class” novel drugs.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$44M
Suzhou Kintor Pharmaceuticals has raised a total of $44M in funding over 2 rounds. Their latest funding was raised on Jan 12, 2018 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 12, 2018 Series C $44M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Suzhou Kintor Pharmaceuticals is funded by 1 investors. China Orient Asset Management (International) Holding are the most recent investors.
Investor Name Lead Investor Funding Round
China Orient Asset Management (International) Holding Series C